
Shionogi Eyes US Plant to Boost Antibiotic Production Amid Tariffs Challenge
United States President Donald Trump has stated plans to gradually increase tariffs on pharmaceuticals to as high as 250%. In response, Shionogi & Company, Limited President Isao Teshirogi announced on August 7 that the firm is considering building a new manufacturing plant in the US.
The facility would produce Cefiderocol (brand name Fetroja), a drug for treating Gram-negative bacterial infections, which is in high demand in the US.
Teshirogi revealed the plan in an interview with The Sankei Shimbun , adding that the plant is expected to be completed by January 2029, while Trump is still in office.
Cefiderocol is currently produced exclusively at Shionogi's factory in Kanegasaki Town, Iwate Prefecture. If the plan goes ahead, the new facility would mark the company's first pharmaceutical manufacturing plant in the US.
The firm is already evaluating the supply chain for the raw materials needed for construction, as well as securing land and personnel for the project. US President Donald Trump speaks at the White House, July 31, Washington (©Reuters via Kyodo)
"If relying entirely on overseas pharmaceutical supplies poses a national security threat, then I agree," Teshirogi said, showing an understanding of Trump's policy. "I believe it's reasonable to want to accelerate and vigorously promote [domestic manufacturing]."
"The ultimate goal is to save patients. If President Trump says, 'I want this product to be made in the US,' then we need to consider building a factory to meet that demand," he added. "We are already developing concrete plans for construction so we can act swiftly in line with the administration's direction."
Regarding financing the project, Teshirogi said, "We will also require subsidies from the US government to support the construction of the new plant." Shionogi Pharmaceutical Research Center in Toyonaka City, Osaka (©Sankei by Yuta Yasumoto)
The drug Cefiderocol is effective against infections caused by multidrug-resistant bacteria, meaning bacteria that have developed resistance to many other antibiotics. It's currently sold in Japan, the United States, and Europe, with demand growing, especially in the US.
Drawing lessons from the COVID-19 pandemic, the Japanese pharmaceutical maker emphasizes the importance of promoting local production overseas to mitigate supply chain risks.
"We are planning to launch Cefiderocol in the US around 2030 or 2040. If we do so, building a factory [there] is unavoidable," the company president said.
However, specialized facilities are required to produce the antibiotics that become the raw materials for Cefiderocol.
Manufacturing these antibiotics is complex, and there seem to be few of these facilities in the US. Therefore, securing skilled engineers could be challenging.
Furthermore, China holds a near-monopoly on the supply of active ingredients for the antibiotics, "making it even more difficult to produce them at fermentation plants in the US," Teshirogi noted.
Shionogi's president acknowledged that transferring manufacturing technology and securing a stable supply of raw materials would be the biggest hurdles ahead.
Author: Yohei Ushijima, Sarasa Shimizu (The Sankei Shimbun)
このページを 日本語 で読む
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CBC
30 minutes ago
- CBC
What Trump's environmental plan targeting key pollution rules means for carmakers
The Environmental Protection Agency's plan this week to relax rules aimed at cleaning up auto tailpipe emissions is the latest Trump administration move to undo incentives for automakers to go electric. As part of a larger effort to undo climate-based governmental regulations, the EPA said it wants to revoke the 2009 finding that carbon dioxide and other greenhouse gases endanger public health and welfare. That would cripple the legal basis for limiting emissions from things like power plants and motor vehicles. President Donald Trump's massive tax and spending law already targets EV incentives, including the imminent removal of a credit that saves buyers up to $7,500 USD on a new electric car. The tax law approved in early July also includes another provision that will hit Tesla and other EV makers in the pocketbook — repealing fines for automakers that don't meet federal fuel economy standards. Automakers can buy credits under a trading program if they don't meet the mileage standards. EV makers like Tesla, which don't rely on gasoline, earn credits that they can sell to other carmakers. The arrangement has resulted in billions of dollars in revenue for Tesla and millions for other EV makers like Rivian. That is all set to go away under the new law. Trump has also challenged federal EV charging infrastructure money and blocked California's ban of new gas-powered vehicle sales. It adds up to less pressure on automakers to continue evolving their production away from gas-burning vehicles. And that's significant because transportation - which also includes ships, trains and planes - is the sector that contributes the most to planet-warming emissions in the U.S. Push and pull on tailpipe and mileage rules Stringent tailpipe emissions and mileage rules were part of the Biden administration's pledge to clean up the nation's vehicles and reduce use of fossil fuels by incentivizing growth in EVs. EVs do not use gasoline or emit greenhouse gases. The Trump administration and the auto industry have said both rules were unreasonable for manufacturers. Automakers could meet EPA tailpipe limits with about 56 per cent of new vehicle sales being electric by 2032 — they're currently at about 8 per cent — along with at least 13 per cent plug-in hybrids or other partially electric cars, and more efficient gasoline-powered cars that get more miles to the gallon. The Department of Transportation Secretary Sean Duffy pressured the National Highway Traffic Safety Administration earlier this year to reverse the rules, and has recently said Biden's inclusion of EVs in calculating them was illegal. NHTSA will likely reset or significantly weaken them. The fines that are going away Then there are the fines that automakers will no longer face for falling short on the fuel economy rules. "With the signing of the One Big Beautiful Bill, new penalties for automakers not complying with an illegal fuel economy standard designed to push EVs will be zero," NHTSA spokesman Sean Rushton said in a statement. Some legacy automakers have paid hundreds of millions of dollars in penalties for not meeting them. Just last year, Jeep-maker Stellantis paid $264-million for model years 2019 and 2020, and General Motors paid $178 million US for the 2016 and 2017 model years. Automakers that didn't meet the standards could also instead buy credits from carmakers that did — or even surpassed them — such as Tesla. That provision earned Tesla $3.9 billion in 2024 — revenue it will no longer see. Elon Musk sharply criticized the big tax-and-spending bill in June, saying it "gives handouts to industries of the past while severely damaging industries of the future." Tesla did not immediately respond to a request for comment on the law's effect on those credits. The agency wrote to carmakers earlier this month informing them the penalties wouldn't be issued from the model year 2022 onward. Some automakers confirmed receiving the letter but declined to comment further. Experts say without them, the law "invites automakers to cheat on government fuel economy rules by setting fines to $0, ensuring consumers will buy more gas guzzlers, pay more at the pump and enrich Big Oil," said Dan Becker, director of the Center for Biological Diversity's Safe Climate Transport Campaign. Ann Carlson, an environmental law professor at the University of California, Los Angeles, and a former acting NHTSA administrator under Biden, called it a "stunning decision" for NHTSA to essentially forgive the fines from 2022 onward. She said it amounted to a windfall for companies that chose to pay penalties rather than produce more efficient cars. Carlson said backing away from future fines also "poses a dilemma for auto manufacturers who may feel bound to comply with the law, even if there is not a financial consequence for failing to do so." Where auto manufacturers go from here It takes a while for carmakers to shift their product lines, and experts say automakers might be locked into their technology and manufacturing decisions for the next few model years. But changes could come for model year 2027 and beyond, they said. EVs aren't as profitable as gas-engine cars, so automakers may make fewer of them if they no longer have to offset emissions from their gasoline models. Already, some automakers have pulled back on their ambitions to go all-electric with a slower pace of EV sales growth. "Automakers also know every presidential administration eventually comes to an end, so they won't abandon their EV development efforts," said Karl Brauer, executive analyst at "But they will reduce their near-term efforts in this area."


CTV News
an hour ago
- CTV News
Barrick Mining reports rise is Q2 profits despite US$1-billion writedown on Mali mine
TORONTO — Barrick Mining Corp. took a US$1.04-billion charge in its second quarter related to its loss of control of a gold mine in Mali, but still reported a rise in profit thanks to higher gold prices and an asset sale. The Toronto-based mining company said Monday it earned US$811 million or 47 cents US per diluted share for the quarter ended June 30, up from US$370 million or 21 cents US per diluted share a year earlier. Profits rose as the price it sold its gold at was up 41 per cent from last year to US$3,295 an ounce. Gold prices have climbed in large part over instability fears raised by the economic policies of the U.S. Trump administration. The higher gold price was offset somewhat by the writedown on the value of its Loulo-Gounkoto mine in Mali, after a June ruling by a judge in the country that it be placed under provisional administration for six months. Barrick Gold has been in conflict with Mali's military rulers over alleged unpaid taxes and unfair contracts with past governments. The dispute culminated in an arrest warrant in December for Barrick CEO Mark Bristow and the company's offer to pay US$370 million to the government. Since then, the government has also arrested Barrick employees, who remain detained, and suspended gold exports, but Bristow said on an conference call Monday that there was still a potential to solve the impasse outside the arbitration process. 'We're not at that stage where we don't believe that we can, you know, find a resolution,' Bristow told the conference call to discuss the company's latest financial results. 'When you're engaging and talking, there's always an opportunity. Of course, there's been some activity in Mali, which complicates the process.' He said the company continues to manage the situation in a measured and constructive manner, continuing with arbitration as it works to find a path forward. While the Mali charge weighed on results, it was also balanced by US$745-million gain in the quarter from the sale of a 50 per cent interest in the Donlin gold project in Alaska. Since quarter end, the company has also announced the sale of its Alturas project in Chile for US$50 million, while it is also in talks to sell Hemlo, its last Canadian gold mine. Bristow said there's a lot of appetite for mines like Hemlo, while the company has added significant gold reserves in recent years to make it a good time to review its holdings. 'It makes sense to rationalize your portfolio from time to time,' he said. 'And it's a good time to do it when there are buyers out there in the market.' In its latest results, Barrick noted Hemlo, which produced 32,000 ounces in the quarter, is not considered a core part of its portfolio. On an adjusted basis, Barrick says it earned 47 cents US per share in its latest quarter, up from an adjusted profit of 32 cents US in the same quarter last year. The mean analyst estimate had been for earnings of 45 cents per share, according to LSEG Data & Analytics. Revenue for the quarter totalled US$3.68 billion, up from US$3.16 billion a year earlier. Gold production in the quarter totalled 797,000 ounces, down from 948,000 a year ago. Copper production totalled 59,000 tonnes, up from 43,000 tonnes a year ago. Overall results were mixed, said RBC analyst Josh Wolfson in a note, with operating results in line with expectations while financial results were noisy in part because of the asset sales. This report by The Canadian Press was first published Aug. 11, 2025. By Ian Bickis


CTV News
an hour ago
- CTV News
ADVERTISEMENT Watch ‘The U.S. holds the most cards in this game': Military analyst on the meeting between Trump, Putin Military Analyst Christian Leuprecht on what to expect from the upcoming meeting between Trump and Putin in Alaska.
Watch Military Analyst Christian Leuprecht on what to expect from the upcoming meeting between Trump and Putin in Alaska.